Federal Regulatory Framework & Advisory Authorities

Statutory Authority & Title 10 Code of Federal Regulations

The regulation of ionizing radiation in the United States derives from the Atomic Energy Act (AEA) of 1954, as amended. The Energy Reorganization Act of 1974 abolished the Atomic Energy Commission, creating the US Nuclear Regulatory Commission (NRC) as an independent regulatory agency with statutory jurisdiction over source, special nuclear, and byproduct materials under Title 10 of the Code of Federal Regulations (10 CFR).

Within healthcare facilities, the NRC enforces three core regulatory parts:

• 10 CFR Part 19: Governs notices, instructions, and reports to radiation workers, employee inspection rights, mandatory posting of NRC Form 3 ("Notice to Employees"), and workers' rights to receive annual exposure reports.
• 10 CFR Part 20: Codifies radiation protection standards, binding occupational and public dose limits, dosimetric summation rules, surveys, radioactive waste management, and the legal requirement to maintain exposures As Low As Reasonably Achievable (ALARA).
• 10 CFR Part 35: Regulates the medical use of byproduct material for diagnostic and therapeutic administrations. Part 35 establishes qualifications for Radiation Safety Officers (RSOs), Authorized Users (AUs), and Authorized Medical Physicists (AMPs); mandates written directives (10 CFR 35.40); regulates dosage calibration and sealed source leak testing; and establishes medical event reporting thresholds (10 CFR 35.3045).

The Energy Policy Act of 2005

Historically, the AEA limited byproduct material to materials produced in nuclear reactors. Accelerator-produced radioactive material (ARM)—including cyclotron PET radionuclides ($^{18}\text{F}$, $^{11}\text{C}$, $^{13}\text{N}$, $^{15}\text{O}$, $^{201}\text{Tl}$, $^{67}\text{Ga}$, $^{111}\text{In}$) and discrete sources of radium-226 and naturally occurring radioactive material (NORM)—were categorized as NARM and regulated exclusively by individual states.

The Energy Policy Act of 2005 (EPAct 2005) permanently expanded the AEA Section 11e definition of byproduct material to include cyclotron-produced radionuclides, discrete sources of Ra-226, and accelerator materials used in commercial, medical, or research activities. Consequently, all accelerator-produced radiopharmaceuticals and discrete NORM sources are now federally regulated under 10 CFR Parts 20, 30, 32, and 35 or corresponding Agreement State codes.

The Agreement State Program & Compatibility Framework

Under Section 274b of the Atomic Energy Act, the NRC enters into formal agreements relinquishing regulatory authority over byproduct, source, and small quantities of special nuclear materials to state governments. These Agreement States (41 states since Indiana's agreement took effect on September 30, 2026) regulate the majority of US medical radiation programs.

Under NRC Management Directive 5.9, each NRC rule is assigned a compatibility category (in addition to an "NRC" category for areas the Commission reserves to itself, such as reactor regulation):

• Category A: Basic radiation protection standards, fundamental definitions, and dose limits (e.g., TEDE limits, tissue weighting factors). State regulations must be essentially identical to federal rules.
• Category B: Cross-jurisdictional program elements (e.g., radioactive materials transportation, reciprocity). State rules must be essentially identical.
• Category C: Essential program objectives where the state must adopt the core intent, but retains flexibility to implement more stringent or restrictive requirements.
• Category D: Regulations not required for compatibility.
• Category H&S: Elements possessing direct health and safety significance that states must adopt, though procedural flexibility is permitted.

The NRC retains non-delegable jurisdiction over nuclear power plants, federal facilities, and international import/export. Crucially, radiation-producing machines (diagnostic x-ray units, CT scanners, linear accelerators) do not involve byproduct material; their registration, clinical operation, and room shielding plans are regulated by state radiation control agencies or OSHA, not the NRC.

Transportation of Radioactive Materials: DOT 49 CFR & Package Classification

Transportation of radioactive materials in commerce is governed by the US Department of Transportation (DOT) under Title 49 CFR Parts 171–178 through a formal Memorandum of Understanding (MOU) with the NRC. DOT oversees shipper packaging, vehicle placarding, carrier routing, and external contamination limits, while the NRC certifies Type B packaging designs (10 CFR Part 71) and inspects licensee shipping procedures.

Radioactive packages are classified by radioactive contents and activity thresholds, specifically $A_1$ (special form sealed source limit) and $A_2$ (normal form unsealed material limit) tabulated in 49 CFR 173.435:

• Excepted Packaging: For limited quantities (e.g., check sources) with surface dose rates $\le 0.005\text{ mSv/hr}$ ($0.5\text{ mrem/hr}$).
• Type A Packaging: Must withstand normal conditions of transport per 49 CFR 173.465 (water spray, free drop from $1.2\text{ m}$, compression, and penetration) without loss of shielding or contents. Used for radiopharmaceutical unit doses up to $A_1$ or $A_2$ (e.g., $^{99\text{m}}\text{Tc}$, $^{131}\text{I}$, $^{18}\text{F}$).
• Type B Packaging: Required for activities exceeding $A_1$ or $A_2$ (e.g., teletherapy $^{60}\text{Co}$ or HDR $^{192}\text{Ir}$ sources). Must survive severe hypothetical accident conditions per 10 CFR Part 71 ($9\text{ m}$ drop onto unyielding surface, $1\text{ m}$ puncture spike drop, $800^\circ\text{C}$ fire for 30 minutes, and water submersion).

Labeling and Transport Index (TI)

Packages require two diamond labels on opposite sides. The Transport Index (TI) is the maximum dose rate in $\text{mrem/hr}$ measured at $1\text{ meter}$ from the surface (rounded up to one decimal place):

• White-I: Surface dose rate $\le 0.005\text{ mSv/hr}$ ($0.5\text{ mrem/hr}$); $1\text{ m}$ dose rate background ($\text{TI} = 0$).
• Yellow-II: Surface dose rate $> 0.005\text{ mSv/hr}$ ($0.5\text{ mrem/hr}$) up to $0.5\text{ mSv/hr}$ ($50\text{ mrem/hr}$); $\text{TI} \le 1.0$ (dose rate at $1\text{ m} \le 0.01\text{ mSv/hr}$ or $1\text{ mrem/hr}$).
• Yellow-III: Surface dose rate $> 0.5\text{ mSv/hr}$ ($50\text{ mrem/hr}$) up to $2.0\text{ mSv/hr}$ ($200\text{ mrem/hr}$); or $\text{TI} > 1.0$ up to $\text{TI} \le 10$. Packages with $\text{TI} > 10$ or surface rate $> 2.0\text{ mSv/hr}$ require exclusive-use vehicles. Vehicle placarding is legally mandatory on all four exterior sides for Yellow-III shipments.

Inter-Agency Delineation: OSHA, FDA/CDRH, and the EPA

Medical radiation safety intersects multiple federal agencies:

• OSHA (29 CFR 1910.1096): Regulates occupational ionizing radiation protection in workplaces outside NRC or Agreement State purview (e.g., industrial x-ray diffraction, chiropractic clinics, and accelerator facilities in non-Agreement states).
• FDA / CDRH (21 CFR Subchapter J): Under the Radiation Control for Health and Safety Act of 1968, the FDA regulates the manufacture and commercial distribution of radiation-emitting electronic devices. Performance standards include 21 CFR 1020.30 (diagnostic x-ray systems), 21 CFR 1020.32 (fluoroscopy entrance air kerma limits: $88\text{ mGy/min}$ [$10\text{ R/min}$] standard mode, $176\text{ mGy/min}$ [$20\text{ R/min}$] high-level control), and the Mammography Quality Standards Act (MQSA; 21 CFR Part 900). Apart from MQSA, which FDA (with certifying states) enforces directly on mammography facilities, FDA's equipment standards bind manufacturers; clinical use of x-ray equipment and operator safety are regulated by the states.
• EPA: Sets Clean Air Act radionuclide emission standards in 40 CFR Part 61. Subpart I now applies only to federal facilities that are not NRC licensees; NRC and Agreement State licensees instead meet the 0.1 mSv (10 mrem) per year air-emission constraint in 10 CFR 20.1101(d), often demonstrated with EPA's COMPLY code. The EPA also issues Federal Guidance Reports (FGR 11 internal dose conversion factors, FGR 12 external coefficients, FGR 13 cancer risk coefficients, FGR 14 diagnostic x-ray guidance) and 40 CFR Part 190 environmental standards.

Scientific Advisory & Standard-Setting Organizations

Statutory rules reflect consensus recommendations from non-regulatory advisory bodies:

• NCRP: Chartered by US Congress in 1964 (Public Law 88-376). Provides scientific guidance forming the basis of US regulations, including Report 116 (dose limitation), Report 147 (diagnostic x-ray shielding), Report 151 (megavoltage vault shielding), Report 160 (population exposure baseline), and Report 168 (fluoroscopic dose management).
• ICRP: International body (Publications 60, 103, 118) defining radiation protection principles: justification, optimization (ALARA), and dose limitation, alongside tissue ($w_T$) and radiation ($w_R$) weighting factors.
• CRCPD: Conference of Radiation Control Program Directors; drafts the Suggested State Regulations for Control of Radiation (SSRCR), establishing model regulations adopted by state programs.
• AAPM & HPS: Professional bodies whose clinical task groups (e.g., AAPM TG-51, TG-108, TG-142) define the accepted standard of medical physics practice.

Regulatory Framework Summary & Clinical Pitfalls

Clinical Practice Pitfalls

1. Classifying Linear Accelerators as Byproduct Material: Linear accelerators produce radiation electronically and contain no byproduct material (unless activated); their operation, shielding, and surveys are governed by state radiation control agencies or OSHA, not 10 CFR Part 35.
2. Assuming Cyclotron Radionuclides Are State-Only: Prior to EPAct 2005, accelerator radionuclides were state-regulated NARM. Today, medical cyclotron isotopes ($^{18}\text{F}$, $^{201}\text{Tl}$) are legally classified as byproduct material under 10 CFR Part 35.
3. Misinterpreting Agreement State Authority: Agreement States may enact more stringent safety rules under Category C compatibility, but cannot relax Category A dose limits or Category B transport standards.